Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Heather M Giannini
Affiliation
ORCID
Career Start Year
2015
Papers
15
H Index
10
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37133589
A Diagnostic Sequence.
2023
35993570
Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort.
Journal of Bronchology and Interventional Pulmonology
2023
36479446
Validating a Proteomic Signature of Severe COVID-19.
Crit Care Explor
2022
35833959
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.
Intensive Care Med
2022
34548135
Genetics of Acute Respiratory Distress Syndrome: Pathways to Precision.
Crit Care Clin
2021
34017137
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Nat Med
2021
33532787
New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19.
medRxiv
2021
33564756
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Res Sq
2021
33653907
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
Sci Immunol
2021
33972943
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
bioRxiv
2021
34521836
New-onset IgG autoantibodies in hospitalized patients with COVID-19.
Nat Commun
2021
31389839
A Machine Learning Algorithm to Predict Severe Sepsis and Septic Shock: Development, Implementation, and Impact on Clinical Practice.
Critical Care Medicine
2019
31135500
Clinician Perception of a Machine Learning-Based Early Warning System Designed to Predict Severe Sepsis and Septic Shock.
Critical Care Medicine
2019
28504649
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.
J Clin Invest
2017
28290285
Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].
Bioorg Med Chem
2015
1 - 15 of 15
Column Actions
Search
Recommended Authors
Collaborators
Nuala J Meyer
University of Pennsylvania Philadelphia
Co-authored papers
9
Michael G S Shashaty
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers
2
Goutham Narla
The University of Michigan Medical School ann arbor
Co-authored papers
2
Nilesh Zaware
Co-authored papers
2
David B Kastrinsky
Co-authored papers
2
Caroline C Farrington
Co-authored papers
2
Michael Ohlmeyer
Atux Iskay LLC
Co-authored papers
2
Alex J Kuo
Co-authored papers
2
Sudeh Izadmehr
Co-authored papers
2
Paul J Utz
Co-authored papers
2
Neil S Dhawan
Co-authored papers
2
Christopher V Cosgriff
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers
2
Kimberly McClinch
Co-authored papers
2
Jaya Sangodkar
University of Michigan ann arbor
Co-authored papers
2
Sarah E Chang
Co-authored papers
1
Divya Hoon
Co-authored papers
1
Lifu Wang
Co-authored papers
1
Edward Y Chen
Co-authored papers
1
Ian Frank
IF School of Medicine, University of Pennsylvania
Co-authored papers
1
Rita A Avelar
Co-authored papers
1
Analisa DiFeo
Co-authored papers
1
Blake E Smith
Co-authored papers
1
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Sahar Mazhar
Co-authored papers
1
Matthew D Galsky
Co-authored papers
1
Rishi R Goel
Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Co-authored papers
1
Rita Tohme
Co-authored papers
1
Shen Yao
Co-authored papers
1
Qiaonan Duan
Co-authored papers
1
Francis P Wilson
Clinical and Translational Research Accelerator, Yale University School of Medicine
Co-authored papers
1
1 - 30